Label: VERUCIDE WART REMOVER KIT- wart remover kit
- NDC Code(s): 63347-720-01, 63347-721-01, 63347-722-01
- Packager: Blaine Labs Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated November 19, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
-
INDICATIONS & USAGE
Uses
■ (for step 1)Antiseptic to decrease bacteria on the skin
■ (for step 2)For the removal of common warts. The common wart is
easily recognized by the rough “cauliflower-like” appearance of the
surface ■ For the removal of plantar warts on the bottom of the foot. The
plantar wart is recognized by its location only on the bottom of the foot,
its tenderness, and the interruption of the footprint pattern - WARNINGS
-
KEEP OUT OF REACH OF CHILDREN
Keep out of reach of children.Stop use and consult a doctor if discomfort
persists. Avoid contact with the eyes. If contact with eye occurs, wash
thoroughly with waterWhen using step 2, do not use: on irritated skin, any area that is infected or
reddened, if you are diabetic, have poor blood circulation, moles, birthmarks,
genital warts, warts with hair growing from them, warts on the face, or
mucous membranesIf swallowed, get medical help or contact a poison control center
right away 1-800-222-1222 -
DOSAGE & ADMINISTRATION
Directions
■ (for step 1)Wash the affected area
with one or two drops
■ ( for step 2)Clean using step 1 and
allow area to dry. Apply a small
amount at a time with applicator to
sufficiently cover each wart and let
dry ■ Let dry ■ Repeat this procedure
once or twice daily as needed (until
wart is removed) for up to 12 weeks - OTHER SAFETY INFORMATION
- INACTIVE INGREDIENT
- QUESTIONS
-
VERUCIDE
®Wart Remover Kit Labeling
BLAINE LABS ` NDC 63347-720-01
VERUCIDE ®
WART REMOVERTWO-STEP WART TREATMENT KIT
SALICYLIC ACID
IN A SOLUTION CONTAINING
ALCOHOL AND PAPAYA EXTRACTKIT INCLUDES:
STEP 1: 0.253 FL OZ (7.5 mL)
STEP 2: 0.101 FL OZ (3.0 mL)Manufactured By:
Blaine Labs, Inc.
11037 Lockport Place
Santa Fe Springs, CA 90670
Step1
Step2
res
-
INGREDIENTS AND APPEARANCE
VERUCIDE WART REMOVER KIT
wart remover kitProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63347-720 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63347-720-01 1 in 1 PACKAGE 09/29/2023 Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE 7.5 mL Part 2 1 BOTTLE 3 mL Part 1 of 2 WART REMOVER STEP 1
alcohol liquidProduct Information Item Code (Source) NDC:63347-721 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ALCOHOL (UNII: 3K9958V90M) (ALCOHOL - UNII:3K9958V90M) ALCOHOL 60 g in 100 mL Inactive Ingredients Ingredient Name Strength GLYCERIN (UNII: PDC6A3C0OX) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER (UNII: 19AH1RAF4M) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63347-721-01 7.5 mL in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M003 10/01/2023 Part 2 of 2 WART REMOVER STEP 2
salicylic acid liquidProduct Information Item Code (Source) NDC:63347-722 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 17 g in 100 mL Inactive Ingredients Ingredient Name Strength ALCOHOL (UNII: 3K9958V90M) WORMWOOD (UNII: F84709P2XV) PAPAYA (UNII: KU94FIY6JB) GLYCERIN (UNII: PDC6A3C0OX) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63347-722-01 3 mL in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M028 10/01/2023 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M028 09/29/2023 Labeler - Blaine Labs Inc. (017314571) Registrant - Blaine Labs Inc. (017314571)